doi.org/10.1186/s12933-021-01390-8
Original paper

Impact of empagliflozin on right ventricular parameters and function among patients with type 2 diabetes

..., Andrew T. Yan
42
Cardiovascular Diabetology8.50
Volume: 20, Issue: 1
Published: Oct 4, 2021
Abstract
Sodium-glucose cotransporter 2 (SGLT2) inhibition reduces cardiovascular events in type 2 diabetes (T2DM) and is associated with a reduction in left ventricular (LV) mass index. However, the impact on right ventricular (RV) remodeling is unknown. Accordingly, the objective of this study was to assess the impact of SGLT2 inhibition on RV parameters and function in T2DM and coronary artery disease (CAD).In EMPA-HEART CardioLink-6, 97 patients with...
Paper Fields
Paper Details
Title
Impact of empagliflozin on right ventricular parameters and function among patients with type 2 diabetes
DOI
doi.org/10.1186/s12933-021-01390-8
Published Date
Oct 4, 2021
Journal
Cardiovascular Diabetology
Volume
20
Issue
1
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.